Rituximab-induced Pulmonary Function Changes
NCT01632124 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2012-06-29
Summary
Measuring lung function (FVC, FEV1, DLCO) before, during and after treatment with rituximab in patients with rheumatoid arthritis or inflammatory myositis.
Conditions
- Rheumatoid Arthritis
- Inflammatory Myositis
Interventions
- OTHER
-
Lung function measurement
Spirometry and measurement of diffusing capacity for carbon monoxide
Sponsors & Collaborators
-
University of Zurich
lead OTHER
Principal Investigators
-
Daniel Franzen, MD · University Hospital Zurich, Division of Internal Medicine
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2013-12-31
- Completion
- 2013-12-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Cardiovascular Risk Markers in Patients With Rheumatoid Arthritis: Effect of Rituximab Therapy
NCT00844714 ·Status: COMPLETED ·Phase: NA
-
Treatment of TNFa Naive Patients With Poor Prognosis Rheumatoid Arthritis
NCT00963703 ·Status: COMPLETED ·Phase: NA
-
A Study on Rheumatoid Arthritis Patients Treated With Rituximab
NCT02622503 ·Status: COMPLETED
-
Relationship Between T LYmphocytes Depletion and Clinical Response to RITUXimab in Rheumatoid Arthritis (LYRITUX)
NCT02304354 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Disease Activity and Modulation of Synovial Lymphoid Structures and B Cell Function in Rheumatoid Arthritis
NCT02528292 ·Status: UNKNOWN
-
Study to Assess the Efficacy and Safety of Rituximab in Patients With Rheumatoid Arthritis
NCT00074438 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Sonographic Efficacy of Rituximab in Rheumatoid Arthritis
NCT01765374 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Safety of Rituximab in Combination With Other Anti-Rheumatic Drugs in Subjects With Active Rheumatoid Arthritis
NCT00443651 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate
NCT00282308 ·Status: COMPLETED ·Phase: PHASE2
-
Dose-finding of Multiple Dose of BT061 in Patients With Active Rheumatoid Arthritis Incompletely Controlled on Stable Methotrexate (MTX)
NCT01481493 ·Status: COMPLETED ·Phase: PHASE2
-
Low Dose Rituximab as a First Line Biologic Therapy for the Treatment of DMARD Resistant Patients With Rheumatoid Arthritis
NCT01593332 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase 2 Study to Evaluate the Safety, Tolerability, and Activity of Fontolizumab in Subjects With Active Rheumatoid Arthritis
NCT00281294 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluation of 200 mg of Rituximab Every 6 Months as Maintenance Treatment of Rituximab-treated Patients With Rheumatoid Arthritis
NCT06906549 ·Status: RECRUITING ·Phase: PHASE4
-
Study Looking at Longitudinal Changes in Fatigue and Health Status in Rheumatoid Arthritis (RA) Patients Treated With Subcutaneous Anti-TNF-α Therapy
NCT01521884 ·Status: COMPLETED
-
Impact of Rituximab on MRI Evidence of Disease Activity in Patients With Moderate to Severe Rheumatoid Arthritis
NCT00425932 ·Status: COMPLETED ·Phase: PHASE2
-
Rituximab Effect on Decreasing glUcoCorticoid Exposition in PolyMyalgia Rheumatica Patients Recently Diagnosed
NCT05533125 ·Status: COMPLETED ·Phase: PHASE3
-
Patients With Rheumatoid Arthritis (RA) Treated With Rituximab in Kuopio University Hospital
NCT00854321 ·Status: COMPLETED
-
An Observational Study of MabThera/Rituxan (Rituximab) and Alternative TNF-Inhibitors in Patients With Rheumatoid Arthritis and an Inadequate Response to a Single Previous TNF-Inhibitor
NCT01557348 ·Status: COMPLETED
-
Atacicept in Combination With Rituximab in Subjects With Rheumatoid Arthritis (August III)
NCT00664521 ·Status: COMPLETED ·Phase: PHASE2
-
RICE: Remission by Intra-articular Injection Plus CErtolizumab
NCT02293590 ·Status: COMPLETED ·Phase: PHASE2
-
Addition of Rituximab to Leflunomide in Patients With Active Rheumatoid Arthritis
NCT01244958 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Condition of Rheumatoid Arthritis After Treatment
NCT02157012 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study on The Safety of Administering Rituximab at A More Rapid Rate in Patients With Rheumatoid Arthritis
NCT01382940 ·Status: COMPLETED ·Phase: PHASE4
-
An Observational Study on Patients With Rheumatoid Arthritis Treated With MabThera (Rituximab)
NCT01075477 ·Status: COMPLETED
-
Stem Cell Support in Patients With Rheumatoid Arthritis
NCT00278551 ·Status: TERMINATED ·Phase: PHASE1